SRNG Financials 07/16/2014 10:13:52 Shelron Group
Post# of 11
Posted On: 07/16/2014 11:13:48 AM
SRNG Financials 07/16/2014 10:13:52
Shelron Group, Inc.
Period Ending Dec 31, 2011 Dec 31, 2010
Total Revenue - 18
Cost of Revenue - -
Gross Profit - 18
Operating Expenses
Research and Development - -
Sales, General and Admin. 241 231
Non-Recurring Items - 1
Other - -
Operating Income (241) (215)
Income From Continuing Operations
Add'l Income/Expense Items 14 -
Earnings Before Interest and Tax (227) (215)
Interest Expense 2 3
Earnings Before Tax (229) (218)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (229) (218)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (229) (218)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (229) (218)
Shelron Group, Inc.
Period Ending Dec 31, 2011 Dec 31, 2010
Total Revenue - 18
Cost of Revenue - -
Gross Profit - 18
Operating Expenses
Research and Development - -
Sales, General and Admin. 241 231
Non-Recurring Items - 1
Other - -
Operating Income (241) (215)
Income From Continuing Operations
Add'l Income/Expense Items 14 -
Earnings Before Interest and Tax (227) (215)
Interest Expense 2 3
Earnings Before Tax (229) (218)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (229) (218)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (229) (218)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (229) (218)
(0)
(0)Ginkgo Bioworks Holdings Inc. (DNA) Stock Research Links
Scroll down for more posts ▼